ACCELERON PHARMA INC's ticker is XLRN and the CUSIP is 00434H108. A total of 271 filers reported holding ACCELERON PHARMA INC in Q2 2021. The put-call ratio across all filers is 1.70 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2021 | $67,549,000 | +4.5% | 392,500 | -23.8% | 0.59% | +11.5% |
Q2 2021 | $64,627,000 | -28.6% | 514,995 | -22.8% | 0.53% | -31.7% |
Q1 2021 | $90,453,000 | -10.3% | 667,010 | -15.3% | 0.78% | -5.4% |
Q4 2020 | $100,811,000 | +5.2% | 787,955 | -7.5% | 0.82% | -8.7% |
Q3 2020 | $95,859,000 | +3.0% | 851,855 | -12.8% | 0.90% | +1.1% |
Q2 2020 | $93,024,000 | +3.6% | 976,420 | -2.3% | 0.89% | -17.2% |
Q1 2020 | $89,809,000 | +50.5% | 999,320 | -11.2% | 1.07% | +101.3% |
Q4 2019 | $59,678,000 | +44.0% | 1,125,575 | +7.3% | 0.53% | +45.0% |
Q3 2019 | $41,442,000 | +10.0% | 1,048,900 | +14.4% | 0.37% | +26.6% |
Q2 2019 | $37,669,000 | -12.1% | 916,970 | -0.4% | 0.29% | -12.1% |
Q1 2019 | $42,878,000 | +38.5% | 920,715 | +29.5% | 0.33% | +23.6% |
Q4 2018 | $30,956,000 | -26.7% | 710,815 | -3.7% | 0.27% | -4.6% |
Q3 2018 | $42,242,000 | +131.1% | 738,115 | +96.0% | 0.28% | +129.5% |
Q2 2018 | $18,275,000 | +40.8% | 376,655 | +13.4% | 0.12% | +38.6% |
Q1 2018 | $12,981,000 | – | 332,005 | – | 0.09% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
GREAT POINT PARTNERS LLC | 917,767 | $52,524,000 | 8.19% |
Foresite Capital Management II, LLC | 220,268 | $12,606,000 | 4.66% |
Foresite Capital Management III, LLC | 250,863 | $14,357,000 | 3.17% |
Novo Holdings A/S | 650,000 | $37,200,000 | 2.95% |
QVT Financial LP | 190,977 | $10,930,000 | 2.82% |
Perceptive Advisors | 1,528,205 | $87,459,000 | 2.34% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,117,651 | $63,963,000 | 2.29% |
Asymmetry Capital Management, L.P. | 39,912 | $2,284,000 | 2.11% |
SECTORAL ASSET MANAGEMENT INC | 298,726 | $17,096,000 | 1.82% |
Stanley-Laman Group, Ltd. | 125,020 | $7,155,000 | 1.76% |